Zhongfeng Huiyu Capsule In The Treatment Of Post-stroke Aphasia (Phlegm-blood Stasis) Clinical Eiffcacy Study

Objective: to apply stroke back-capsule in the treatment of post-stroke aphasia (Syndrome ofintermingled phlegm and blood stasis) clinical efficacy studies, to achieve the desired objectives,improve curative effect, reduce the pain of the patient, early return to society.Methods: a randomized, controlled method. According to the random number table, divided intothe treatment group30examples, the control group In30cases. The use of the United States ofAmerica NIH Stroke Scale (NIHSS) standards of grading. To meet the diagnostic criteria, inclusioncriteria, and then by exclusion criteria, selected as subjects. Through the China Rehabilitation Center"standard aphasia examination table" on a strict screening, to further improve the cases into groups, inorder to achieve the best effect, application of Zhongfeng Huiyu capsule in the treatment ofpost-stroke aphasia (Syndrome of intermingled phlegm and blood stasis) clinical efficacy studies, choiceof post-stroke aphasia (motor aphasia60cases), two groups of the number of cases is1:1. Amongthe30cases of the control group, giving the base treatment;30cases in the treatment group, on thebasis of medicine based on the use of Zhongfeng Huiyu capsule. After two weeks, patients wereobserved the recovery, and through various language evaluation standards were analyzed statisticallyvalidated, thereby improving its clinical effects.Results: after statistical analysis, the treatment group (applied basis for medication plusZhongfeng Huiyu capsule) the total efficiency of86.37%, compared to the control group (baseline)the total efficiency of73.33%, compared to two groups, the difference is significant (P <0.05),results showed that the treatment group was superior to control group, curative effect. Clinical trialsshow that: the application of Zhongfeng Huiyu capsule in the treatment of post-stroke aphasia(Syndrome of intermingled phlegm and blood stasis) clinical efficacy studies significantly, and canobviously improve the patients' clinical symptoms and signs.Conclusion: Zhongfeng Huiyu capsule in the treatment of post-stroke aphasia (Syndrome ofintermingled phlegm and blood stasis) clinical efficacy studies, has provided the theory basis, this topicwill be implemented for post-stroke aphasia treatment options, provide valuable clinical experience, thereby reducing the patient's treatment of cost, has very high practical value, social benefits, but alsoenables the patient to regain confidence in life, early return to society. Therefore, by adopting themethod of experimental and clinical research, obtained remarkable result, be worth to be in clinical inthe wide application of.